NIH-funded research R01 grant

Understanding how EndoU affects cell death and cancer development

Official title: Function and mechanism of EndoU

Funded at University of California Riverside · NIH-10982360 · Data updated 2026-11-12

This study is looking at a protein called EndoU to understand how it helps control cell death and its effects on different cancers, which could lead to new ways to treat these diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Riverside
NIH-funded
Lab location1 site (Riverside, United States)
Project startSeptember 15, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$376,876
NIH project number1R01GM152548-01A1
Project IDNIH-10982360 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with uterine, cervical, skin, bronchial, lung, esophageal, oral squamous, or colorectal cancers.

Less likely to help

Patients with cancers not associated with EndoU misregulation or those without a cancer diagnosis may not benefit from this research.

What this research studies

This research investigates the role of a protein called EndoU, which is involved in the regulation of cell death and cancer. The study aims to uncover how EndoU functions at a molecular level, particularly how it is activated by calcium ions and its impact on various types of cancer. By examining EndoU's activity in cell cultures, researchers hope to clarify its role in cellular responses and its potential as a prognostic marker for certain cancers. This could lead to new insights into cancer biology and treatment strategies.

Why it matters

Potential benefit: If successful, this research could provide new targets for cancer therapies and improve prognostic assessments for patients with specific types of cancer.

How similar studies have gone: Previous research has shown promising results in understanding RNA-binding proteins and their roles in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California Riverside
    Riverside, United States
    Active

Researchers

  • Principal investigator: Karginov, Fedor V — University of California Riverside
  • Study coordinator: Karginov, Fedor V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.